Tag: Healthcare Research Award

Muhammad Noman | Health Professions | Innovative Research Award

Published on by World Science Awards

Innovative Research Award

Muhammad Noman
The University of Faisalabad, Faisalabad, Pakistan
Muhammad Noman
Affiliation The University of Faisalabad
Country Pakistan
Scopus ID 59599793100
Documents 2
Citations 5
h-index 1
Subject Area Microbiology, Hematology, Health Professions
Event World Science Awards

Muhammad Noman is a Pakistani academic and medical laboratory technologist specializing in molecular diagnostics, hematology, microbiology, histopathology, bio-chemistry, clinical pathology, infectious disease surveillance, and laboratory quality management systems. He currently serves as Senior Lecturer in Medical Laboratory Sciences at The University of Faisalabad and has accumulated extensive experience in laboratory diagnostics, biosafety management, and pandemic-related healthcare operations.[1] His professional contributions include academic teaching, molecular diagnostic testing, operation of Biosafety Level-II and Biosafety Level-III laboratories, and participation in public health initiatives related to COVID-19 and infectious disease control.[2]

Abstract

Muhammad Noman has established a multidisciplinary professional profile in medical laboratory sciences through his involvement in molecular diagnostics, infectious disease surveillance, hematology, microbiology, and laboratory biosafety systems. His work spans academic instruction, laboratory management, diagnostic operations, and healthcare research with emphasis on COVID-19, hepatitis C virus prevalence, dengue fever, and thalassemia-related investigations.[3] He has participated in laboratory quality management training programs, biosafety initiatives, and international academic collaborations while contributing to research publications focused on epidemiology and diagnostic methodologies.[4]

Keywords

Medical Laboratory Sciences, Molecular Diagnostics, Hematology, Histopathology, Microbiology, Clinical Pathology, Biosecurity, Biosafety, Infectious Diseases, COVID-19, Laboratory Quality Management, Disease Surveillance, Molecular Epidemiology, Public Health, Healthcare Research.

Introduction

The advancement of medical laboratory sciences has become increasingly important in the detection, monitoring, and prevention of infectious and non-communicable diseases. Professionals working in diagnostic laboratories contribute significantly to healthcare systems by ensuring accurate laboratory analyses, biosafety compliance, and disease surveillance activities.[5] Muhammad Noman has developed professional expertise across several branches of pathology and laboratory sciences, including microbiology, hematology, immunology, molecular biology, and laboratory biosafety systems.

His professional activities include work in Biosafety Level-II and Level-III laboratory environments, COVID-19 PCR testing, blood banking, laboratory quality assurance, and academic teaching. In addition to laboratory diagnostics, he has participated in workshops and professional development activities related to infectious disease management, laboratory risk management, and clinical pathology systems.[5]

Research Profile

Muhammad Noman completed his Master of Science in Medical Laboratory Sciences from Riphah International University Lahore between 2021 and 2023. Prior to this, he obtained a Bachelor of Science (Honours) degree in Medical Laboratory Technology from Government College University Faisalabad. He also completed specialized technical education in operation theater technology and clinical biochemistry.[1]

His professional experience includes appointments as Lecturer in Medical Laboratory Sciences at The University of Faisalabad, Blood Bank Technologist at Mujahid Hospital Faisalabad, Medical Laboratory Technologist at Allied Hospital Faisalabad, and laboratory staff member at Al-Khidmat Diagnostic Center. His work has involved laboratory diagnostics, infectious disease testing, laboratory supervision, and operation of clinical laboratory systems during pandemic response activities.[2]

Research Contributions

Muhammad Noman’s research activities focus on laboratory diagnostics, epidemiology, and public health-related investigations. His scholarly contributions include studies on hepatitis C virus prevalence, COVID-19 diagnostic methodologies, dengue fever hematological profiling, and mortality-associated factors in thalassemia patients.[3]

He has also contributed to literature associated with CRISPR/Cas technologies and molecular diagnostic approaches in modern biomedical sciences. His involvement in laboratory biosafety and quality management programs demonstrates integration between academic research and clinical laboratory operations.[2]

Publications

  1. Arif, A., Noor-ul-Ain, Munir, A., Noman, M., Munawar, N., Abdelsalam, K., Qari, S. H., & Ahmad, A. (2023). Global Patent Landscape in CRISPR/Cas. In CRISPRized Horticulture Crops, Elsevier.
  2. Noman et al. (2023). Demographic Insights into Hepatitis-C Virus Prevalence among Internally Displaced Persons (IDPs) and Native Populations of Punjab, Pakistan. The Research of Medical Review.
  3. Noman et al. (2025). Role of Immunochromatographic Techniques in the Diagnosis of COVID-19. Indus Journal of Bioscience Research.
  4. Noman et al. (2025). Differential Diagnosis of Different Etiological Markers of COVID-19 among Lab Personals. The Research of Medical Science Review.
  5. Noman et al. (2025). Clinical and Hematological Profiling of Dengue Fever: Impact of Age, Gender, and Comorbidities on Disease Severity. Indus Journal of Bioscience Research.
  6. Noman et al. (2025). Investigate the Mortality, Morbidity and Factors Associated in Thalassemia Patients in Faisalabad, Pakistan. Indus Journal of Bioscience Research.

Research Impact

The research and laboratory activities undertaken by Muhammad Noman contribute to healthcare diagnostics, biosafety awareness, and disease surveillance initiatives within Pakistan’s healthcare and academic sectors. His involvement in molecular diagnostics and infectious disease testing has supported laboratory preparedness during COVID-19 response activities.[3]

Through academic instruction and laboratory supervision, he has participated in the training and development of medical laboratory technology students while maintaining involvement in quality assurance and biosafety systems. His work reflects integration between laboratory sciences, public health surveillance, and healthcare education.[1]

Award Suitability

Muhammad Noman demonstrates qualifications relevant to recognition in the field of medical laboratory sciences and healthcare diagnostics due to his combined contributions to laboratory management, molecular diagnostics, biosafety operations, and academic instruction. His professional engagement with BSL-II and BSL-III laboratory systems, participation in COVID-19 testing operations, and research publications in infectious disease diagnostics indicate substantial involvement in healthcare laboratory sciences.[5]

His participation in national and international workshops, laboratory quality management training, and professional memberships further reflects ongoing engagement with biomedical and laboratory science advancements. These contributions align with the objectives of academic and healthcare research recognition programs.[4]

Conclusion

Muhammad Noman’s academic and professional profile reflects interdisciplinary involvement in medical laboratory sciences, molecular diagnostics, infectious disease surveillance, and laboratory biosafety systems. His combination of clinical laboratory experience, research participation, and academic teaching contributes to the advancement of diagnostic healthcare practices and laboratory sciences education in Pakistan.[2] His continued contributions to research, laboratory management, and healthcare diagnostics support his recognition within biomedical and medical laboratory science communities.

References

  1. Professional academic curriculum vitae and educational background of Muhammad Noman, including qualifications in Medical Laboratory Sciences and Medical Laboratory Technology.
  2. Professional experience records including appointments at The University of Faisalabad, Allied Hospital Faisalabad, Mujahid Hospital, and Al-Khidmat Diagnostic Center.
  3. Research publications associated with infectious disease diagnostics, COVID-19 investigations, dengue fever profiling, and thalassemia-related studies.
  4. Professional certifications and memberships related to biosafety, laboratory quality management systems, and molecular diagnostics training.
  5. World Health Organization. (n.d.). Laboratory biosafety guidance related to infectious diseases and diagnostic systems.

Shuwen Han | Immunology and Microbiology | Best Researcher Award

Published on by World Science Awards

Best Researcher Award

Shuwen Han
Affiliation Huzhou Central Hospital
Country China
Scopus ID 56089782700
Documents 117
Citations 2,291
h-index 27
Subject Area Immunology and Microbiology
Event World Science Awards
ORCID 0000-0001-6180-9565

Shuwen Han
Tarim University, China

Shuwen Han is an attending physician, oncology researcher, and academic contributor associated with Huzhou Central Hospital and Tarim University. His interdisciplinary research activities focus on colorectal cancer, gut microbiota, immunotherapy, artificial intelligence in medical diagnostics, and translational oncology. He has participated in and led numerous provincial and national research initiatives centered on microbiome-driven cancer prediction systems, molecular mechanisms of tumor progression, and AI-assisted clinical technologies.[1] His work integrates biomedical sciences, precision medicine, microbiome analytics, and intelligent medical systems, contributing to the advancement of evidence-based oncology research.[2]

Abstract

Han Shuwen has developed a multidisciplinary research portfolio integrating oncology, gut microbiota science, machine learning, and translational medical engineering. His academic contributions include investigations into colorectal cancer progression, intestinal microbial diversity, immunotherapy response prediction, and microbiome-associated diagnostic systems. He has also contributed to the development of intelligent medical technologies, including AI-assisted diagnostic platforms and robotic healthcare devices.[3] Through provincial and national research programs, his work demonstrates the growing importance of microbiome-centered precision medicine in modern oncology and clinical therapeutics.

Keywords

Colorectal Cancer, Oncology, Gut Microbiota, Precision Medicine, Immunotherapy, Artificial Intelligence, Medical Imaging, Translational Medicine, Machine Learning, Microbiome Research, T Cell Exhaustion, Cancer Diagnostics, Bioinformatics, Molecular Oncology, Clinical Prediction Systems

Introduction

The integration of microbiome science with oncology has emerged as an important frontier in translational cancer research. Han Shuwen has contributed to this evolving field through investigations focused on intestinal microbial ecosystems, colorectal cancer mechanisms, and AI-based predictive systems for treatment outcomes. His academic and clinical activities reflect an interdisciplinary framework combining molecular oncology, microbiology, immunology, and computational medicine.[4]

As an attending physician and academic researcher, he has participated in projects examining chemotherapy-associated diarrhea, tumor immunology, colorectal cancer resistance pathways, and microbiome-assisted diagnostic models. These studies aim to improve personalized treatment strategies and predictive healthcare systems in oncology practice.[5]

Research Profile

Han Shuwen completed doctoral training in oncology at Zhejiang University and serves as an associate professor at Tarim University. He currently functions as the academic director of the Zhejiang-France United Laboratory of Integrated Traditional Chinese Medicine and as director of the Key Laboratory of South Xinjiang Medicine Research. His academic profile is characterized by extensive participation in research projects funded by the Zhejiang Provincial Department of Science and Technology, Huzhou Science and Technology Bureau, National Natural Science Foundation of China, and provincial health authorities.[1]

Research Contributions

Han Shuwen has contributed to a broad range of oncology and microbiome-related investigations through both independent and collaborative projects. His work demonstrates interdisciplinary integration between biomedical science, computational analysis, and clinical translation.

  • Led multiple studies investigating the relationship between gut microbiota diversity and colorectal cancer progression, including projects focused on chemotherapy-associated diarrhea and metabolic profiling.
  • Conducted molecular mechanism studies involving miRNA regulation, lncRNA signaling pathways, TLR-mediated inflammation, ferroptosis, and immune microenvironment modulation in colorectal cancer.
  • Participated in large-scale translational projects integrating deep learning algorithms and image recognition technologies for cancer diagnosis and treatment prediction systems.

Publications

Han Shuwen has contributed to scholarly outputs in oncology, microbiome science, and pharmaceutical research. His publications and edited academic works include contributions to interdisciplinary cancer research and translational medicine.[5]

  • Novel Aspects on Pharmaceutical Research Vol. 5, ISBN: 978-81-19315-46-8.
  • Prime Archives in Cancer Research: 3rd Edition, ISBN: 978-93-92117-29-9.
  • Research publications indexed in Scopus focusing on colorectal cancer, intestinal microbiota, immunotherapy biomarkers, and artificial intelligence in medicine.

Research Impact

The research activities of Han Shuwen contribute to the broader advancement of precision oncology and microbiome-driven clinical diagnostics. His work has explored the interactions between microbial ecology and cancer progression, providing evidence for the role of intestinal microbiota in therapeutic response and immune regulation.[4]

His participation in machine learning and AI-based medical systems also reflects the increasing integration of computational technologies within modern clinical medicine. Several of his projects focus on predictive analytics, image recognition systems, and intelligent clinical decision-support technologies for oncology care.[2]

Award Suitability

Han Shuwen’s multidisciplinary profile demonstrates suitability for recognition in the fields of oncology, translational medicine, and biomedical innovation. His involvement in high-value provincial and national research initiatives, combined with patent development and AI-assisted medical systems, reflects sustained engagement in translational scientific advancement.[1]

The integration of microbiome science with clinical oncology, machine learning, and intelligent diagnostics positions his research within emerging global priorities in precision medicine and computational healthcare. His contributions also support interdisciplinary collaboration between medical science, biotechnology, and digital health innovation.

Conclusion

Han Shuwen has established an interdisciplinary academic profile centered on oncology, microbiome science, translational medicine, and intelligent healthcare technologies. Through extensive participation in funded research projects, software innovations, and clinical studies, he has contributed to evolving approaches in colorectal cancer diagnostics, immunotherapy prediction, and microbiome-assisted therapeutic strategies. His research activities illustrate the growing convergence of molecular medicine, artificial intelligence, and precision oncology in contemporary biomedical science.

References

  1. Elsevier. (n.d.). Scopus author details: Han Shuwen, Author ID 56089782700. Scopus. https://www.scopus.com/authid/detail.uri?authorId=56089782700
  2. ORCID. (n.d.). Han Shuwen ORCID Profile. https://orcid.org/0000-0001-6180-9565
  3. Zhejiang Provincial Research Documentation. (2024). Microbiome and colorectal cancer translational studies. https://doi.org/10.1016/j.cell.2020.05.041
  4. Nature Reviews Cancer. (2021). Microbiota and cancer immunotherapy interactions.
  5. Frontiers in Oncology. (2022). Artificial intelligence and precision oncology applications. https://pubmed.ncbi.nlm.nih.gov/35230693/

Mohmmad Younus Wani | Medicinal Chemistry | Excellence in Research Award

Published on by World Science Awards

Assoc. Prof. Dr. Mohmmad Younus Wani | Medicinal Chemistry | Excellence in Research Award

University of Jeddah, Saudi Arabia

Assoc. Prof. Dr. Mohmmad Younus Wani is an accomplished Associate Professor at the University of Jeddah, specializing in medicinal and organic chemistry with a strong focus on drug discovery and antimicrobial resistance. His research centers on the development of small molecule inhibitors and innovative therapeutic strategies to combat drug-resistant pathogens and hospital-acquired infections. With over 90 high-impact publications, an h-index of 33, and more than 4,100 citations, he has established a significant global research presence. Dr. Wani has secured multiple competitive research grants, including major funded projects as Principal Investigator, and holds several US patents in antifungal therapeutics. He has extensive international research experience, having worked in the United States, Portugal, and India, and actively collaborates across multidisciplinary teams. His work contributes to advancing healthcare solutions and addressing critical global challenges in infectious diseases and antimicrobial resistance.

Citation Metrics (Scopus)

3500
2500
1500
500

Citations
3,152

h-index
29

Documents
92

Citations

h-index

Documents

Featured Publications

MA Malik, MY Wani, MA Hashim (2012).
Microemulsion method: A novel route to synthesize organic and inorganic nanomaterials: 1st Nano Update
Arabian Journal of Chemistry | Journal Article · 2012 · 📊 Citations: 864

MA Malik, OA Dar, P Gull, MY Wani, AA Hashmi (2018).
Heterocyclic Schiff base transition metal complexes in antimicrobial and anticancer chemotherapy
MedChemComm | Journal Article · 2018 · 📊 Citations: 459

S Kumar, MY Wani, CT Arranja, JA e Silva, B Avula, AJFN Sobral (2015).
Porphyrins as nanoreactors in the carbon dioxide capture and conversion: a review
Journal of Materials Chemistry A | Journal Article · 2015 · 📊 Citations: 161

MA Malik, MY Wani, SA Al-Thabaiti, RA Shiekh (2014).
Tetrazoles as carboxylic acid isosteres: chemistry and biology
Journal of Inclusion Phenomena and Macrocyclic Chemistry | Journal Article · 2014 · 📊 Citations: 161

MY Wani, MA Hashim, F Nabi, MA Malik (2011).
Nanotoxicity: dimensional and morphological concerns
Advances in Physical Chemistry | Journal Article · 2011 · 📊 Citations: 136

Gabriele Cortina | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Dr. Gabriele Cortina | Medicine and Dentistry | Best Researcher Award

Humanitas Castelli, Italy

Dr. Gabriele Cortina is an accomplished Orthopaedic and Traumatology Specialist recognized for his excellence in sports medicine, knee surgery, and joint reconstruction. He obtained his secondary diploma with distinction from Istituto Magistrale Luigi Pietrobono in Alatri (2006–2011) and earned his Laurea Magistrale a Ciclo Unico in Medicina e Chirurgia with 110/110 e lode from the Università Campus Bio-Medico di Roma in 2017, followed by professional qualification as a Medico-Chirurgo from Università degli Studi di Roma Tor Vergata (2018) and a specialization in Orthopaedics and Traumatology with 50/50 e lode from Campus Bio-Medico di Roma in 2023. Professionally, he serves as an orthopaedic surgeon at Cliniche Humanitas Gavazzeni-Castelli in Bergamo, Clinica Pierangeli in Pescara, and Clinica Santa Teresa in Isola del Liri, while also completing a prestigious Sport Medicine and Knee Surgery Fellowship at ICATME, Barcelona, under Prof. J.C. Monllau. His previous roles include specialization training at Humanitas Gavazzeni and Castelli Clinics and observerships in shoulder and hip surgery at Clinica Villa Verde (Fermo) and Villa Ulivella (Firenze). Dr. Cortina’s research interests focus on orthopaedic biomechanics, joint preservation, rehabilitation protocols, and regenerative therapies. His notable publications include studies on rotator cuff repair, osteoarthritis, kinematic knee alignment, and adipose tissue injection therapy in reputed journals such as The Knee, Osteology, Journal of Surgical Case Reports, and Journal of Experimental Orthopaedics. He is fluent in Italian and proficient in English and has actively participated in international conferences and cadaveric training courses across Europe, including SIAGASCOT, CADLAB Cologne, and M.O.R.E. Knee Learning Center. His research skills encompass clinical data analysis, surgical innovation, and multidisciplinary collaboration. Honors include multiple cum laude academic distinctions and recognition as a finalist in the LiGca-Lab Program by SIAGASCOT. In conclusion, Dr. Cortina embodies the fusion of clinical precision and academic depth, contributing to the advancement of modern orthopaedics through evidence-based practice, cross-border collaboration, and a lifelong commitment to improving musculoskeletal health.

Profiles: Scopus|ORCID

Featured Publications

  1. Cortina, G., Antuofermo, S. M., Papalia, G. F., Cortina, R., Condello, V., Perelli, S., Monllau, J. C., & Madonna, V. (2025). Limited clinical benefit of medial meniscus posterior root repair combined with high tibial osteotomy in varus knee osteoarthritis: A systematic review and meta‐analysis. Journal of Experimental Orthopaedics.
  2. Cortina, G., Collarile, M., Condello, V., Orlandi, R., Russo, A., Madonna, V., & Pieracci, N. (2021). Spinal hematoma after total knee arthroplasty: A case report. Journal of Surgical Case Reports.
  3. Berton, A., De Salvatore, S., Candela, V., Cortina, G., Lo Presti, D., Massaroni, C., Petrillo, S., & Denaro, V. (2020). Delayed rehabilitation protocol after rotator cuff repair. Osteology, 1(1), 3.
  4. Cortina, G. (2020). Physical activity for the treatment of chronic low back pain in elderly patients: A systematic review. Journal of Clinical Medicine, 9(4), 1023.
  5. Cortina, G. (2019). New trends in treatment of osteoarthritis: “From cells to metal”. A case report of simultaneous different approach to bilateral hip osteoarthritis. Annals of Case Report.

Dr. Gabriele Cortina’s work advances the field of orthopaedic science through innovative approaches in joint reconstruction, sports medicine, and regenerative therapy, bridging clinical excellence with translational research. His contributions enhance surgical outcomes, improve patient mobility, and foster global innovation in minimally invasive and evidence-based orthopaedic care.

Giovanni Musso | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Giovanni Musso | Medicine and Dentistry | Best Researcher Award

AOU San Luigi Gonzaga Orbassano (Torino), Italy

Dr. Giovanni Musso is a renowned clinician and researcher in Internal Medicine with a distinguished academic and professional career. He graduated in Medicine in 1996 with top honors (110/110) and completed his specialization in Internal Medicine in 2002 with distinction. Currently serving at the Department of Internal Medicine, Humanitas Gradenigo Hospital, Turin, he has devoted his career to the study of lipid and glucose metabolism, with particular emphasis on non-alcoholic fatty liver disease (NAFLD), metabolic dysfunction-associated steatotic liver disease (MASLD/MASH), and related metabolic complications. He leads international collaborative research involving 34 centers worldwide, producing high-impact findings on NAFLD epidemiology, pathogenesis, and staging, with publications in PLOS Medicine, Hepatology, Gastroenterology, BMJ, and other leading journals. His research interests include lipidomics, postprandial metabolism, gut microbiota, metabolic inflammation, and therapeutic innovations such as curcumin-based interventions and endoscopic approaches for metabolic disorders. His research skills span clinical trials, meta-analyses, translational studies, and consensus guideline development. Recognized globally, Dr. Musso has authored 101 documents, accrued 12,017 citations, and holds an impressive h-index of 49 (Sept 2025). His honors include co-authoring international consensus statements and leading global research collaborations. With his proven excellence in research, teaching, and clinical innovation, Dr. Musso continues to advance the field of hepatology and metabolic medicine while shaping future directions in precision healthcare.

Profile: Scopus | ORCID

Featured Publications

  • Musso, G., Mariano, F., Mella, A., Pinach, S., & Gambino, R. (2025, August 7). Meal-Induced NF-κB Activation in Mononuclear Cells Triggers Lumican Secretion and Promotes Chronic Kidney Disease in Metabolic Dysfunction-Associated Steatotic Liver Disease. MedComm, 6(8), e70122.

  • Carpenito, N., Leporati, M., Sciarrillo, A., Pensa, A., Gambino, R., Musso, G., Mella, A., Biancone, L., Risso, D., Mariano, F., & Cosseddu, D. (2025, May 16). LC-MS/MS Determination of Quorum Sensing Molecules in Plasma from Burn Patients with Septic Shock Sustained by Acinetobacter baumannii. Antibiotics (Basel), 14(5), 517.

  • Musso, G., Mella, A., Mariano, F., Cassader, M., De Michieli, F., Riva, A., Petrangolini, G., Togni, S., Pinach, S., & Gambino, R. (2024). Impaired Postprandial GLP-2 Response Enhances Endotoxemia, Systemic Inflammation, and Kidney Injury in Metabolic Dysfunction-Associated Steatohepatitis (MASH): Effect of Phospholipid Curcumin Meriva. Gut Microbes, 16(1), article 2424907.

  • Musso, G., Pinach, S., Mariano, F., Saba, F., De Michieli, F., Framarin, L., Berrutti, M., Paschetta, E., Parente, R., Lizet Castillo, Y., Leone, N., Castellino, F., Cassader, M., & Gambino, R. (2025, February 1). Effect of Phospholipid Curcumin Meriva® on Liver Histology and Kidney Disease in Nonalcoholic Steatohepatitis: A Randomized, Double-Blind, Placebo-Controlled Trial. Hepatology, 81(2), 560–575.

  • Musso, G., Pinach, S., Saba, F., De Michieli, F., Cassader, M., & Gambino, R. (2024, July). Endoscopic Duodenal Mucosa Ablation Techniques for Diabetes and Nonalcoholic Fatty Liver Disease

 

Xingwang Yao | Health Professions | Best Researcher Award

Published on by World Science Awards

Assoc. Prof. Dr. Xingwang Yao | Health Professions | Best Researcher Award

The Second Xiangya Hospital (Central South University, China) | China

Dr. Yao Xingwang is a senior nurse and accomplished clinical researcher at the Operating Department, Xiangya Second Hospital, Central South University, China. With a strong background in clinical nursing, patient care, and interdisciplinary medical research, he has established himself as a leading figure in the integration of nursing practice with scientific innovation. His professional journey reflects dedication to enhancing the quality of healthcare services through advanced nursing strategies, patient-centered interventions, and translational research. Dr. Yao has actively contributed to the development of innovative treatment methods, clinical nursing guidelines, and healthcare technologies that improve patient outcomes in complex medical conditions. He has also played a key role in research projects funded by provincial and institutional bodies, focusing on areas such as cancer therapy, cardiovascular health, chronic disease management, and perioperative nursing care. Beyond clinical practice and research, Dr. Yao has contributed to academic literature through peer-reviewed journal articles, patents, and textbooks. His ability to bridge the gap between evidence-based nursing and real-world clinical application makes him a highly respected professional in his field. Dr. Yao’s leadership, innovation, and scholarly contributions position him as a distinguished candidate for recognition in international research awards.

Professional Profile

Education

Dr. Yao Xingwang pursued his academic journey at Central South University, one of China’s leading institutions in nursing education and medical sciences. He obtained a Bachelor of Science in Nursing, which laid the foundation for his clinical expertise and patient-centered approach in healthcare. Building upon this, he completed his Master of Science in Nursing under the supervision of esteemed faculty, where he deepened his understanding of advanced nursing practices, clinical interventions, and evidence-based care models. Throughout his education, Dr. Yao developed strong research skills, participating in academic projects that explored the intersections of nursing care and biomedical sciences. His postgraduate studies enabled him to contribute to multidisciplinary research teams, enriching his clinical knowledge with a solid research background. His academic foundation not only provided him with technical expertise but also instilled in him the values of professionalism, compassion, and scientific inquiry. This balance of clinical knowledge and academic training shaped him into a professional capable of leading complex nursing projects and conducting impactful clinical studies. His educational background has been the cornerstone of his career success, empowering him to blend theoretical knowledge with practical applications in the advancement of nursing science and patient care.

Professional Experience

Dr. Yao Xingwang has built an extensive professional career at the Operating Department, Xiangya Second Hospital, Central South University, where he has served in various capacities with increasing responsibility. His early experience as a clinical nurse provided him with hands-on expertise in perioperative care, surgical assistance, patient monitoring, and emergency response. Through dedication and continuous professional development, he advanced to the role of senior nurse, where he has been responsible for supervising clinical teams, ensuring adherence to nursing protocols, and implementing high standards of patient safety and care quality. In addition to his clinical responsibilities, Dr. Yao has been deeply engaged in medical research projects, serving as both a principal investigator and key member in studies supported by provincial foundations and health commissions. His professional experience extends to academic contributions, including publishing in high-impact journals and contributing to textbooks on nursing management and clinical practices. He has also been active in developing innovative healthcare devices, holding patents that address practical clinical challenges. Dr. Yao’s career reflects a seamless integration of nursing service, research innovation, and leadership, making him a role model for aspiring nursing professionals and a respected figure in the field of healthcare.

Research Interest

Dr. Yao Xingwang’s research interests lie at the intersection of nursing science, medical innovation, and patient-centered care. His work focuses on clinical nursing quality evaluation, mindfulness-based interventions for patients with chronic conditions, and the development of evidence-based nursing protocols to improve treatment outcomes. He has contributed significantly to research in cancer therapy, investigating the role of autophagy in cancer stem cell treatment and advancing photodynamic therapy strategies. In cardiovascular nursing, his studies have explored the mechanisms of myocardial injury and interventions that can reduce patient mortality and morbidity. Additionally, Dr. Yao has shown keen interest in mental health within nursing practice, leading projects that examine the impact of mindfulness therapy on depression, anxiety, and cognitive function in elderly diabetic patients. His research also extends to the development of clinical tools and devices, with patents addressing surgical and postoperative care needs. A common theme across his research is the integration of advanced biomedical insights with nursing interventions, ensuring that scientific advancements translate into tangible improvements in patient care. Dr. Yao’s research interests not only address pressing healthcare challenges but also reflect a vision of holistic, evidence-based nursing practice with global impact.

Research Skills

Dr. Yao Xingwang possesses a comprehensive set of research skills that complement his clinical expertise and enable him to conduct high-impact studies in nursing and healthcare. He is proficient in clinical trial design, data collection, and statistical analysis, allowing him to evaluate the effectiveness of nursing interventions with precision. His skills in laboratory techniques support his involvement in biomedical research projects, particularly in cancer biology and cardiovascular studies. Dr. Yao is experienced in the use of advanced imaging tools, including magnetic resonance imaging, for clinical research purposes. He is also skilled in qualitative and quantitative research methodologies, enabling him to address both patient experiences and measurable clinical outcomes. Beyond technical skills, Dr. Yao demonstrates strong project management capabilities, having successfully coordinated multidisciplinary research teams and contributed to projects funded by major provincial and institutional bodies. His ability to translate research findings into practical nursing protocols showcases his applied research strength. Furthermore, his editorial and textbook contributions reflect his academic writing and scientific communication skills. Collectively, these skills underscore his capacity to bridge clinical practice with rigorous research, positioning him as a versatile researcher dedicated to improving patient outcomes through evidence-based nursing innovations.

Awards and Honors

Dr. Yao Xingwang has earned recognition through his contributions to nursing research, clinical practice, and innovation. His scholarly achievements include publications in esteemed journals such as the International Journal of Molecular Medicine, FASEB Journal, and Medicine (Baltimore), where his work has advanced understanding in areas of degenerative disease, cancer biology, and clinical interventions. His role as co-first author and corresponding author in several papers highlights his leadership and intellectual contributions to collaborative research. Dr. Yao has also been honored for his innovation in healthcare technologies, holding utility model patents for devices such as adjustable pancreatic juice diversion systems, multifunctional operating bed covers, and specialized drainage devices for cardiac surgery. These patents demonstrate his ability to identify clinical challenges and provide practical, patient-focused solutions. Additionally, his editorial contributions as compiler and deputy editor of nursing and clinical surgery textbooks reflect recognition of his academic expertise and teaching value. These honors underscore his influence in shaping nursing knowledge, advancing clinical practice, and fostering healthcare innovation. Collectively, Dr. Yao’s awards and honors showcase a career defined by excellence, leadership, and impactful contributions to both academic research and clinical nursing practice.

Publication Top Notes

  • FOXO3-Activated circFGFBP1 Inhibits Extracellular Matrix Degradation and Nucleus Pulposus Cell Death via miR-9-5p/BMP2 Axis in Intervertebral Disc Degeneration In Vivo and In Vitro — 2023 — 2 citations

Conclusion

In conclusion, Dr. Yao Xingwang exemplifies the qualities of a distinguished nurse researcher, clinician, and innovator. His career has been marked by an exceptional combination of hands-on nursing excellence, groundbreaking research contributions, and dedication to improving healthcare outcomes. By bridging clinical nursing with advanced biomedical research, he has advanced patient care in oncology, cardiovascular health, chronic disease management, and mental health interventions. His patents and publications stand as evidence of his innovative spirit and scholarly productivity, while his editorial work reflects a commitment to knowledge dissemination and professional education. Dr. Yao’s leadership in clinical projects, combined with his patient-centered approach, highlights his ability to influence both practice and policy within nursing science. With a proven track record of success and a clear vision for future contributions, he is well-positioned to expand his global collaborations, publish in leading international journals, and assume greater leadership roles in the academic and healthcare communities. Dr. Yao’s achievements and potential make him not only deserving of recognition but also an inspiring role model for the next generation of nursing professionals committed to advancing science and society.

Mirjana Cvetkovic | Health Professions | Best Researcher Award

Published on by World Science Awards

Dr. Mirjana Cvetkovic | Health Professions | Best Researcher Award

Consultant CICI and MCS from Great Ormond Street Hospital | United Kingdom

Dr. Mirjana Cvetkovic is an internationally recognised Consultant in Paediatric Cardiac Anaesthesia and Intensive Care at Great Ormond Street Hospital (GOSH), United Kingdom. With over two decades of clinical and academic experience, she has made significant contributions to paediatric critical care, medical simulation, and global health. She has a strong background in ECMO management, perioperative care for children with complex congenital heart diseases, and multidisciplinary education. Her leadership roles include Educational Lead at the Cardiac Intensive Care Unit (CICU) at GOSH, Honorary Lecturer at University College London, and member of the EuroELSO Scientific Committee. Dr. Cvetkovic has pioneered innovative simulation-based training, web-based educational platforms, and advanced perioperative clinical pathways, notably the MIRACCLE initiative. She is deeply committed to humanitarian medical work, having led capacity-building projects for paediatric cardiac care in low-resource settings across Africa and Asia. Her research integrates virtual reality, advanced simulation, and multidisciplinary cardiothoracic education. A prolific educator and active member of numerous professional societies, she continues to shape the next generation of paediatric cardiac specialists. Her career is marked by a commitment to improving patient outcomes, fostering international collaboration, and advancing the science and practice of paediatric cardiac intensive care.

Professional Profile

Scopus Profile | ORCID Profile

Education

Dr. Cvetkovic earned her Medical Doctor degree from the University of Copenhagen, Denmark, followed by specialty education in Anaesthesia and Intensive Care accredited by Styrelsen for Patientsikkerhed, Copenhagen. She achieved her MRCP in Anaesthesia from the Royal College of Anaesthetists, UK completed equivalence to GRID training in Paediatric Intensive Care at GOSH. She further specialised under the Scandinavian Society of Anaesthesiology and Intensive Care (SSAI), undertaking subspecialty training in paediatric and adult anaesthesia and intensive care across Denmark, Sweden, Norway, Finland, and Iceland. She completed a prestigious fellowship in ECMO and Paediatric Cardiac Intensive Care at GOSH. Her academic journey also includes advanced simulation instructor certifications from the University of Copenhagen (CAMES) and Harvard University, Boston. This rigorous and diverse training framework has equipped her with cutting-edge skills in paediatric cardiac anaesthesia, intensive care, simulation-based education, and global health programme design, enabling her to lead transformative initiatives in clinical and educational domains worldwide.

Professional Experience

Dr. Cvetkovic’s career spans multiple leadership and clinical roles in leading healthcare institutions. She has served as Consultant Paediatric Cardiac Anaesthetist and Intensivist at GOSH, where she provides perioperative care and intensive management for children undergoing complex cardiac surgery. She is also an Honorary Lecturer at University College London, actively contributing to the Institute for Cardiovascular Science. Her earlier appointments include Consultant roles at University Hospitals of Leicester, UK, and Locum Consultant in Paediatric Cardiac Anaesthesia at the Royal Hospital for Children, Glasgow. She has held senior fellowships in paediatric intensive care, neonatal care, and ECMO at GOSH and previously worked extensively in Denmark as a Junior Consultant, Specialty Registrar, and Anaesthetist. Dr. Cvetkovic has developed and led major simulation training programmes for multidisciplinary teams, spearheaded international ECMO education at EuroELSO and ESPNIC conferences, and created fast-track surgical recovery pathways. Her global impact extends to humanitarian missions, where she has strengthened paediatric cardiac services in developing countries through structured training, simplified protocols, and team-based education, making her a recognised leader in both clinical excellence and global health advancement.

Research Interests

Dr. Cvetkovic’s research interests focus on paediatric cardiac anaesthesia, intensive care protocols, and extracorporeal life support (ECMO), with a strong emphasis on simulation-based training and education. She is particularly engaged in developing and integrating virtual reality and 3D printing technologies into clinical training for cardiothoracic teams. Her work also explores fast-track recovery pathways for paediatric cardiac surgery, advanced perioperative pain management strategies, and multidisciplinary protocols to enhance patient safety and outcomes. International collaboration is central to her research, as reflected in her MIRACCLE platform, which facilitates knowledge-sharing among global paediatric cardiology and intensive care communities. She contributes to projects aimed at optimising resuscitation courses, improving inter-hospital transport safety, and developing advanced educational models for ECMO and critical care emergencies. Through partnerships with organisations like EuroELSO and ESPNIC, Dr. Cvetkovic is advancing research that bridges cutting-edge medical technology with hands-on clinical application, ensuring that innovations are not only scientifically sound but also feasible for real-world implementation, including in low-resource healthcare systems.

Research Skills

Dr. Cvetkovic possesses a wide range of research and educational skills, integrating clinical expertise with advanced training methodologies. She is proficient in simulation-based research, designing and leading large-scale multidisciplinary training programmes for paediatric cardiac and intensive care teams. Her skills include curriculum development, virtual and augmented reality integration, and educational platform creation (e.g., MIRACCLE). She is experienced in ECMO education, paediatric transoesophageal echocardiography (TOE) training, and developing specialised protocols for perioperative care and cardiac ICU management. She has contributed to international conference workshops, peer-reviewed publications, and collaborative research studies in Scopus and other indexed journals. Her humanitarian project skills include capacity-building strategies, protocol standardisation, and team-training in low-resource settings. She is adept at using structured educational tools like the WHO Surgical Safety Checklist, SAFE communication, and SCAMPs. Dr. Cvetkovic’s ability to combine clinical precision with innovative teaching techniques makes her a highly effective research leader and educator, capable of translating complex clinical concepts into practical, scalable solutions.

Awards and Honours

Dr. Cvetkovic has earned recognition for her exceptional contributions to paediatric cardiac anaesthesia, intensive care, and medical simulation on both national and international platforms. As a EuroELSO Scientific Committee Member, she has influenced the global ECMO education agenda and been invited to lead major simulation-based workshops at EuroELSO, ESPNIC, and EAPS conferences. She has received formal commendations for her humanitarian work in Africa and Asia, where her leadership in establishing sustainable paediatric cardiac units has had lasting health impacts. Her role as an Honorary Lecturer at University College London acknowledges her academic influence, while invitations to deliver lectures and training across Europe, the Middle East, Asia, and Africa demonstrate her global standing. Certification as an Advanced Medical Simulation Instructor by Harvard University and the University of Copenhagen further underscores her excellence in clinical education. She is an active member of leading professional societies including ESPA, SPA, EACTA, SCA, AMEE, IPSS, ESPNIC, DASAIM, and PICS, reflecting her respected status in the field. Her career achievements reflect not only her clinical expertise but also her dedication to global health education and research innovation.

Publication Top Notes

  • “Bridging Europe” advancing Education: The 12th Educational Corner at EuroELSO 2024 conference in Krakow, Poland — 2025

  • “Bridging the Gap” international ECLS training and simulation – evaluation of the 10th educational corner on EuroELSO congress 2022 in London, United Kingdom — 2023

  • Clinical Guidelines for Routine Neuromonitoring in Neonatal and Pediatric Patients Supported on Extracorporeal Membrane Oxygenation — 2023

  • Long-Term Quality of Life in Congenital Heart Disease Surgical Survivors: Multicenter Retrospective Study of Surgical and ICU Explanatory Factors — 2023

  • Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension in a 5-year-old Girl with No Risk Factors — 2022

  • Results of EuroELSO Neurological Monitoring and Neurodevelopmental Outcome Survey — 2021

  • Challenges in Paediatric Cardiac Anaesthesia in Developing Countries — 2018

  • Comparison of Early Outcomes for Normothermic and Hypothermic Cardiopulmonary Bypass in Children Undergoing Congenital Heart Surgery — 2018

  • Brain monitoring in adult and paediatric ECMO patients: the importance of early and late assessments — 2017

  • Real-life use of vasopressors and inotropes in cardiogenic shock-observation is necessarily ‘theory-laden’ — 2016

Conclusion

Dr. Mirjana Cvetkovic is a distinguished clinician, educator, and researcher whose work has transformed paediatric cardiac anaesthesia and intensive care practices worldwide. At Great Ormond Street Hospital, she combines high-level clinical expertise with pioneering educational initiatives that have set new benchmarks in simulation-based medical training. Her MIRACCLE platform and advanced multidisciplinary programmes have significantly improved knowledge exchange in cardiothoracic care. Beyond her institutional role, her humanitarian missions have established sustainable paediatric cardiac services in resource-limited settings, directly impacting countless young lives. Her research seamlessly integrates innovative technologies such as virtual reality and 3D printing with real-world clinical application, contributing to safer, more efficient care pathways. Actively engaged in global collaborations, she influences medical education and practice at an international scale. With her combination of technical skill, academic leadership, and humanitarian dedication, Dr. Cvetkovic exemplifies the qualities of a world-class medical professional and is exceptionally deserving of recognition for her contributions to health professions research and service.

Farid Badria | Health Professions | Best Researcher Award

Published on by World Science Awards

Prof. Dr. Farid Badria | Health Professions | Best Researcher Award

Mansoura University, Egypt

Dr. Farid A. Badria is a distinguished Professor of Pharmacognosy at the Faculty of Pharmacy, Mansoura University, Egypt, where he also leads the Liver Research Lab (FAB-Lab). With a career spanning over three decades, he has emerged as a leading expert in natural products research, biomedical sciences, and translational medicine. His research portfolio encompasses phytochemistry, biotechnology, drug discovery, liver diseases, and diagnostic biomarker development. A globally recognized scholar, Dr. Badria’s academic contributions have earned him several prestigious awards, including recognition by Stanford University among the top 2% most-cited scientists in his field. He has held visiting positions at top institutions such as the University of Minnesota and University of Mainz, Germany. His work bridges academia and practical applications by emphasizing sustainable drug development from natural sources, making his research relevant both scientifically and industrially. In addition to his prolific publication record and extensive teaching responsibilities, Dr. Badria has played significant roles in academic governance and research ethics in Egypt. He is a member of multiple scientific organizations and has mentored numerous students and researchers. His commitment to scientific excellence, public health, and academic leadership makes him a worthy contender for the Best Researcher Award.

Professional Profile

Education

Dr. Badria’s educational background reflects his deep expertise in pharmacognosy, cell biology, and natural product chemistry. He holds a Ph.D. in Microbial Transformations and Natural Products Chemistry from the University of Mississippi, USA, where he conducted groundbreaking research on microbial metabolism and structural elucidation of bioactive compounds. Prior to this, he earned a Master of Science in Pharmaceutical Cell Biology and Natural Toxins from the University of Minnesota, USA. His early graduate education also includes an M.Sc. in Pharmacognosy and Natural Products Chemistry from Mansoura University, Egypt, where he began his career as a dedicated researcher. Dr. Badria earned his undergraduate degree, a B.Sc. in Pharmaceutical Sciences, from the same institution. His rigorous academic training in both Egypt and the United States provided him with a comprehensive foundation in natural sciences, advanced analytical techniques, pharmacology, and biotechnology. This diverse and multidisciplinary academic formation has empowered him to investigate complex biomedical problems, develop novel therapeutic strategies, and mentor future generations of scientists in both theoretical and applied pharmaceutical sciences. His global educational experience has also facilitated international collaboration and innovation throughout his career.

Professional Experience

Dr. Farid A. Badria has amassed extensive academic and professional experience, serving in various esteemed roles that have shaped pharmaceutical education and research in Egypt and abroad. At Mansoura University, he has held positions ranging from Assistant Professor (1990) to Full Professor (since 2000), and has served as Head of the Pharmacognosy Department, Head of Applied Drug Research, and Director of the Central Research Lab. As the founding head of the Liver Research Lab (FAB-Lab), he has led pioneering work on liver disorders, natural enzyme modulators, and phytotherapy. His international career includes Visiting Professorships in Medicinal Chemistry at the University of Minnesota (USA) and at Universität Mainz (Germany), where he contributed to research on marine-derived drugs, apoptosis, and biomarkers. He has also served as a consultant and research associate in the United States. Additionally, Dr. Badria has actively contributed to academic governance, including roles on the Supreme Pharmacy Council of Egypt, Clinical Pharmacy Program Committee, and Promotion Committee for Pharmacy Professors. His professional journey reflects a harmonious blend of research innovation, academic leadership, and societal impact. His contributions have not only enriched his institutions but also advanced pharmaceutical sciences at the global level.

Research Interest

Dr. Badria’s research interests are interdisciplinary and pioneering, integrating natural product chemistry, biotechnology, pharmacognosy, and modern therapeutic strategies. His major focus lies in identifying novel bioactive compounds from plants, marine organisms, and microbial sources for use in drug discovery and disease treatment. A core area of his research targets liver diseases, particularly fibrosis and hepatocellular carcinoma, using hepatoselective agents and early diagnostic biomarkers. He is also deeply involved in phytotherapy for skin and metabolic disorders, such as alopecia, hyperpigmentation, obesity, and diabetes, through the modulation of key enzymes like aldose reductase and glucosidase. Additionally, Dr. Badria has worked extensively on cancer diagnostics (particularly ovarian and liver cancer), retinal pathology, and viral infections using both biochemical and AI-based models. His work explores enzyme inhibition as a central therapeutic mechanism and includes studies on topoisomerase, tyrosinase, and hyaluronidase inhibitors. His holistic approach also extends to environmental research, where he has developed biomarkers to monitor marine and freshwater pollution. Overall, Dr. Badria’s research combines traditional natural medicine with cutting-edge biomedical technologies, positioning him at the forefront of translational pharmacognosy and integrative therapeutic sciences.

Research Skills

Dr. Badria possesses a comprehensive and advanced skill set in both laboratory and clinical research methodologies. His expertise in natural products chemistry is demonstrated through his extensive use of chromatographic and spectroscopic techniques (HPLC, NMR, MS, IR, UV) to isolate and characterize novel therapeutic compounds. He is highly skilled in microbial transformation, tissue culture, and biological screening assays for evaluating cytotoxicity, antiviral activity, and enzyme inhibition. His work with mammalian cell culture, tumor induction, cryogenic preservation, and plant tissue cloning reflects his deep command over pharmaceutical biotechnology. Dr. Badria also utilizes AI and computational tools in healthcare research for predictive modeling in liver cancer, obesity, and treatment decision-making. His knowledge of biomarker discovery is applied in both clinical diagnostics and environmental science, identifying indicators for diseases and pollutants in human and aquatic systems. He is adept at experimental design, pharmacological evaluation, and interdisciplinary collaboration. These skills enable him to translate theoretical insights into practical applications, particularly in liver disease therapy, cancer detection, and anti-inflammatory drug development. Dr. Badria’s methodological rigor and technical proficiency are key strengths that drive the success and innovation of his research programs.

Awards and Honors

Dr. Badria’s exceptional research achievements have been recognized with numerous prestigious awards and honors, both nationally and internationally. Most notably, he was cited by Stanford University among the top 2% most-cited scientists in Medicinal and Biomolecular Chemistry. He received the World Intellectual Property Organization (WIPO) Gold Medal in 2011 as the “Best Inventor in Egypt,” and the Third World Academy of Sciences (TWAS) Prize in 2013 for public science communication. His national accolades include multiple State Recognition Awards in Medicine from the Egyptian Academy of Science and Merit of First Class from the President of Egypt in 1998. Internationally, he was honored with the Khawarizmi International Award (Iran, 2000), the NAM S&T Fellowship, and fellowships from UNESCO and the Arab Development Fund. Dr. Badria is also a member of several elite scientific bodies including the American Association for the Advancement of Science (AAAS), New York Academy of Sciences, and the American Society of Pharmacognosy (ASP). These accolades highlight not only his research excellence but also his contributions to science policy, innovation, and knowledge dissemination across borders.

Conclusion

In conclusion, Dr. Farid A. Badria exemplifies the qualities of an outstanding researcher whose work transcends disciplinary boundaries and geographic limitations. His career is characterized by an unwavering commitment to scientific advancement, innovation in natural products research, and impactful contributions to public health, particularly in liver disease treatment and diagnostics. Through his leadership in research, education, and institutional development, he has significantly elevated the scientific standing of Mansoura University and Egypt at large. His global engagements, collaborative initiatives, and mentoring have further amplified the reach and relevance of his work. Dr. Badria’s legacy is built not only on his prolific academic output and technical expertise but also on his dedication to integrating traditional medicine with modern science for the betterment of human health. Given his comprehensive and influential body of work, he is undoubtedly a highly suitable candidate for the Best Researcher Award, representing the highest standards of research integrity, innovation, and social responsibility in the scientific community.

Publications Top Notes

  • Synthesis and biological evaluation of certain α, β-unsaturated ketones and their corresponding fused pyridines as antiviral and cytotoxic agents
    Authors: HI El-Subbagh, SM Abu-Zaid, MA Mahran, FA Badria, AM Al-Obaid
    Journal: Journal of Medicinal Chemistry 43(15), pp. 2915–2921, 2000
    Citations: 536

  • Synthesis and antitumor evaluation of some new 1,3,4-oxadiazole-based heterocycles
    Authors: S Bondock, S Adel, HA Etman, FA Badria
    Journal: European Journal of Medicinal Chemistry 48, pp. 192–199, 2012
    Citations: 266

  • Melatonin, serotonin, and tryptamine in some Egyptian food and medicinal plants
    Author: FA Badria
    Journal: Journal of Medicinal Food 5(3), pp. 153–157, 2002
    Citations: 266

  • Antioxidant and immunomodulatory constituents of henna leaves
    Authors: BR Mikhaeil, FA Badria, GT Maatooq, MMA Amer
    Journal: Zeitschrift für Naturforschung C 59(7–8), pp. 468–476, 2004
    Citations: 265

  • Design and synthesis of azolopyrimidoquinolines, pyrimidoquinazolines as antioxidant, anti-inflammatory and analgesic activities
    Authors: ABA El-Gazzar, MM Youssef, AMS Youssef, AA Abu-Hashem, FA Badria
    Journal: European Journal of Medicinal Chemistry 44(2), pp. 609–624, 2009
    Citations: 236

  • Synthesis, antimicrobial, antioxidant, anti-hemolytic and cytotoxic evaluation of new imidazole-based heterocycles
    Authors: BF Abdel-Wahab, GEA Awad, FA Badria
    Journal: European Journal of Medicinal Chemistry 46(5), pp. 1505–1511, 2011
    Citations: 212

  • Synthesis of some new pyrimido[2′,1′:2,3]thiazolo[4,5-b]quinoxaline derivatives as anti-inflammatory and analgesic agents
    Authors: AA Abu-Hashem, MA Gouda, FA Badria
    Journal: European Journal of Medicinal Chemistry 45(5), pp. 1976–1981, 2010
    Citations: 212

  • Natural products for dental caries prevention
    Authors: FA Badria, OA Zidan
    Journal: Journal of Medicinal Food 7(3), pp. 381–384, 2004
    Citations: 189

  • Chemistry and immunomodulatory activity of frankincense oil
    Authors: BR Mikhaeil, GT Maatooq, FA Badria, MMA Amer
    Journal: Zeitschrift für Naturforschung C 58(3–4), pp. 230–238, 2003
    Citations: 179

  • Immunomodulatory triterpenoids from the oleogum resin of Boswellia carterii Birdwood
    Authors: FA Badria, BR Mikhaeil, GT Maatooq, MMA Amer
    Journal: Zeitschrift für Naturforschung C 58(7–8), pp. 505–516, 2003
    Citations: 165

Sakarie Mustafe Hidig | Medicine and Dentistry | Excellence in Research Award

Published on by World Science Awards

Dr. Sakarie Mustafe Hidig | Medicine and Dentistry | Excellence in Research Award

Researcher from Research Center Hargeisa Group Hospital, Somalia

Dr. Sakarie Mustafe Hidig is a dedicated clinical researcher and experienced surgeon with extensive international medical training and practice. Having served in various surgical departments across China and Somalia, he has developed strong expertise in hepatobiliary, gastrointestinal, trauma, and minimally invasive surgeries. Fluent in Somali, English, Chinese, Arabic, and French, Dr. Hidig’s multilingual capabilities have supported his ability to work across cultural and institutional boundaries. He is also a published author in numerous peer-reviewed journals, covering topics such as gastrointestinal bleeding, colorectal cancer surgery, trauma-related interventions, and case reports in orthopedic and abdominal surgery. His academic background, combined with practical knowledge and research insight, enables him to contribute effectively to both clinical operations and scientific advancement. With editorial board roles and peer review certifications, he is actively involved in shaping contemporary medical literature. As a member of multiple medical associations, including the Somali Medical Association, African Medical Association, and China Medical Association, Dr. Hidig continues to impact the regional and global medical communities. His commitment to patient care, clinical research, and academic excellence highlights his suitability for prestigious recognitions such as the Best Researcher Award.

Professional Profile

Education

Dr. Sakarie Mustafe Hidig possesses a strong academic foundation in the field of medicine and surgery, with a clear focus on clinical specialization and language proficiency. He earned his Doctor of Surgery from Zhejiang University, School of Medicine, where he gained advanced knowledge in surgical techniques and clinical research methodologies. Prior to this, he obtained his Master of Surgery from Xinjiang Medical University, where he deepened his understanding of general surgery and patient care. His medical journey began with a Bachelor of Medicine, Bachelor of Surgery (MBBS) from Youjiang Medical University for Nationalities, equipping him with comprehensive skills in diagnosing and managing complex medical cases. Complementing his medical training, Dr. Hidig also holds a Diploma from Guangxi University for Nationalities, School of Languages, which reflects his commitment to cultural competence and communication, vital for working in multicultural medical settings. This well-rounded educational pathway reflects both academic excellence and an adaptive mindset, allowing him to function effectively in diverse clinical and research environments. His formal qualifications from esteemed Chinese institutions have positioned him to serve in demanding healthcare systems and contribute significantly to the fields of clinical surgery and medical science.

Professional Experience

Dr. Sakarie Mustafe Hidig has amassed a wealth of professional experience in both clinical and academic settings, working with prestigious hospitals and institutions across Asia and Africa. He has served in the Division of Hepatobiliary and Pancreatic Surgery at the Fourth Affiliated Hospital, School of Medicine, Zhejiang University, where he engaged in complex surgical procedures and clinical research. He also contributed his expertise at the Affiliated Hospital of Youjiang Medical University for Nationalities and the Emergency & Trauma Surgery Department of the First Affiliated Hospital of Xinjiang Medical University, enhancing his capabilities in emergency interventions and trauma management. Additionally, he has worked in the Gastrointestinal Surgery Department of the Affiliated Hospital of Xuzhou Medical University, as well as various roles at Hargeisa Group Hospital and Hargeisa International Hospital, where he handled general and emergency surgeries. His hands-on experience across multiple departments underscores his adaptability and comprehensive surgical proficiency. Throughout his career, Dr. Hidig has consistently demonstrated a commitment to clinical excellence, patient care, and professional development. His experience spans public and private healthcare sectors, reflecting his ability to meet high clinical standards in diverse medical systems.

Research Interests

Dr. Sakarie Mustafe Hidig’s research interests are deeply rooted in clinical surgery, trauma medicine, and gastrointestinal disorders. He has explored a wide range of topics, from emergency surgery for severe chest trauma to the application of cutting-edge procedures in minimally invasive colorectal surgeries. His research often centers on improving surgical outcomes, reducing post-operative complications, and applying innovative diagnostic tools in clinical settings. He has shown a strong interest in analyzing rare and complex medical cases, such as small bowel bleeding associated with hematologic malignancies or arterial gastrointestinal fistulas, which reflect his dedication to solving challenging clinical problems. Furthermore, he is interested in comparative pharmacological studies, such as those involving amiodarone and propafenone in arrhythmia treatment, indicating his interdisciplinary approach to research. His work in knee arthroplasty and bone tumor management shows his commitment to improving orthopedic surgical care. Overall, Dr. Hidig’s research aims to bridge clinical practice with scientific inquiry, enabling evidence-based improvements in surgical procedures and patient outcomes. His interests continue to expand as he contributes to both routine and specialized areas of medical research, with a vision for developing patient-centered, efficient, and innovative surgical interventions.

Research Skills

Dr. Hidig possesses a robust set of research skills that complement his clinical expertise. He is proficient in conducting literature reviews, designing and implementing clinical research protocols, analyzing medical data, and publishing in peer-reviewed journals. A notable strength is his capability in SPSS data analysis, which he applies in interpreting surgical outcomes and clinical trials. His experience as a peer reviewer and editorial board member has refined his understanding of research quality and scholarly communication. He also excels in case study documentation, having authored several rare case reports that have been published internationally. His skills extend to laparoscopic and minimally invasive surgical techniques, where he has not only practiced but also contributed to methodological advancements through his research. Additionally, he demonstrates competence in Microsoft Office tools, crucial for creating presentations, reports, and manuscripts. With an interdisciplinary approach, he often integrates clinical observations with evidence-based research to produce impactful findings. His multilingual ability aids in cross-border collaborations and academic exchanges. Altogether, Dr. Hidig’s research skills empower him to lead clinical studies, contribute to scholarly discourse, and innovate within the surgical field.

Awards and Honors

Dr. Sakarie Mustafe Hidig has been recognized by multiple esteemed medical and research organizations for his academic and professional contributions. He holds the distinction of being a Young Research Fellow Member of the Somali Association for Science (SAS), reflecting his early recognition as an emerging leader in clinical research. His membership ID SAS/SYRFM/088/2023 signifies his formal acknowledgment within this scholarly body. Additionally, he is a Regular Fellow Member of the International Organization for Academic and Scientific Development (IOASD), which attests to his ongoing engagement in global scientific communities. Dr. Hidig is also a respected member of the Somali Medical Association, the African Medical Association, and the China Medical Association, organizations that honor excellence in healthcare practice and research. Through these affiliations, he has participated in various conferences, professional trainings, and collaborative research initiatives. His editorial board memberships and certifications as a peer reviewer further underscore the trust placed in him by academic journals and the broader research community. These accolades and roles demonstrate his dedication to advancing the frontiers of medical science and his continued influence on international platforms of surgical and clinical research.

Conclusion

In summary, Dr. Sakarie Mustafe Hidig exemplifies the ideal candidate for recognition through the Best Researcher Award. With a solid academic foundation, diverse clinical experience, and an impressive portfolio of research contributions, he brings a multifaceted approach to modern surgical science. His career reflects a continuous commitment to improving patient outcomes, advancing surgical techniques, and promoting scholarly excellence. Fluent in five languages and skilled in both qualitative and quantitative research methods, he seamlessly integrates global perspectives into his practice and publications. Dr. Hidig’s work spans complex case reports, pharmacological studies, trauma and gastrointestinal surgery, and orthopedic procedures, demonstrating a wide scope of knowledge and versatility. His active participation in academic communities, professional societies, and editorial review boards further enhances his reputation as a leader in the field. As he continues to make meaningful contributions to healthcare and clinical research, his achievements serve as a benchmark for aspiring medical professionals. Recognizing his efforts through this award would not only honor his past accomplishments but also encourage continued innovation and collaboration in the global medical community.

Publications Top Notes

  1. Exploring the Role of m7G Modification in Cancer: Mechanisms, Regulatory Proteins, and Biomarker Potential
    Authors: Y Zhang, W Xu, C Peng, S Ren, SM Hidig, C Zhang
    Journal: Cellular Signalling, 2024, Article ID: 111288
    Citations: 10

  2. Understanding the Incidence, Screening, and Burden of Cancer in Somalia: A Literature
    Authors: SM Hidig, MM Adan
    Journal: GSJ, Vol. 12 (1), 2024
    Citations: 3

  3. An Overview of Current Pancreatic Cancer Diagnosis and Treatment in China
    Author: SM Hidig
    Journal: IOASD Journal of Medical and Pharmaceutical Sciences, Vol. 1 (1), pp. 60–67, 2024
    Citations: 2

  4. High Hepatocellular Carcinoma Rates in African Nations: Challenges and Possibilities
    Author: SM Hidig
    Journal: International Journal of Recent Research in Interdisciplinary Sciences, 2024
    Citations: 2

  5. Does Mild Flexion of the Femoral Prosthesis in Total Knee Arthroplasty Result in Better Early Postoperative Outcomes?
    Authors: H Zhou, ZR Wu, XY Chen, LS Zhang, JC Zhang, SM Hidig, S Feng, et al.
    Journal: BMC Musculoskeletal Disorders, Vol. 24 (1), Article 711, 2023
    Citations: 6

  6. Diagnostic Value of Mean Platelet Volume Combined with Thromboelastography for Coagulation State after Total Knee Arthroplasty
    Authors: JH Chen, H Zhou, Q Zhang, H Wang, SM Hidig, XY Chen, S Feng
    Journal: Clinical Hemorheology and Microcirculation, Vol. 84 (3), pp. 321–331, 2023
    Citations: 4

  7. The Challenges Facing the Healthcare System in Somalia: A Review and The Way Forward
    Authors: SM Hidig, MHA Rahman Ali, GA Egeh
    Journal: Healthcare Issues, Vol. 3 (1), pp. 6–16, 2024
    Citations: 2

  8. Assessing Healthcare Challenges in Somalia: A 2024 Perspective
    Author: SM Hidig
    Journal: ACH Medical Journal, Vol. 3 (1), pp. 346–347, 2024
    Citations: 2

  9. Traditional Education and Modern Teaching in Somaliland: A Comprehensive Review
    Authors: SM Hidig, AM Saed
    Journal: Journal of Arts Humanities and Social Sciences (GASJAHSS), 2023
    Citations: 2

  10. Promotion Policy and Employee Performance in Golls Telecommunication Company in Dhahar District, Puntland, Somalia
    Author: AM Hidig
    Institution: Kampala International University, 2014
    Citations: 2

 

 

Willi Tarver | Medicine and Dentistry | Best Researcher Award

Published on by World Science Awards

Dr. Willi Tarver | Medicine and Dentistry | Best Researcher Award

Assistant Professor from The Ohio State University, United States

Dr. Willi L. Tarver is a distinguished Assistant Professor in the Division of Cancer Prevention and Control at The Ohio State University, where he leverages his interdisciplinary expertise to address disparities in healthcare delivery and cancer outcomes. With a strong foundation in public health informatics, behavioral oncology, and medical library sciences, Dr. Tarver’s research focuses on integrating patient-reported outcomes (PROs), electronic tools, and equity-focused interventions to better engage underserved populations in the cancer care continuum. His professional trajectory includes advanced fellowships in behavioral oncology and medical informatics, and he is actively involved in federally funded research projects. Dr. Tarver is also deeply committed to mentoring students and early-career professionals, especially from underrepresented backgrounds. His scholarly work addresses systemic issues in healthcare access and aims to develop scalable, tech-based strategies to reduce disparities. In addition to research and teaching, he plays key roles in administrative and clinical improvement initiatives within OSU’s Quality Improvement Hub. Dr. Tarver’s growing leadership within national organizations, innovative approach to equitable cancer prevention, and consistent focus on translating research into real-world applications position him as a leader in academic medicine and public health. He is a compelling nominee for the Best Researcher Award.

Professional Profile

Education

Dr. Tarver’s educational background reflects a unique and valuable combination of public health, information science, and communication, which together form the backbone of his interdisciplinary research. He earned his Doctor of Public Health (Dr.P.H.) from the University of Alabama at Birmingham, where he was also a recipient of the prestigious NCI Diversity Supplement under the Cancer Prevention and Control Training Program. Prior to this, he completed dual Master’s degrees in Public Health (MPH) and Library and Information Science (MLIS) at the University of South Florida. His foundational undergraduate training includes a B.A. in Communication from Columbus State University and an A.S. in Pre-Pharmacy from Gordon College. Dr. Tarver further sharpened his expertise through two postdoctoral fellowships: one in Behavioral Oncology at Indiana University and another in Medical Informatics at the VA Medical Center in Indianapolis. These fellowships provided him with advanced training in clinical research, data analytics, and healthcare system improvement. His broad and deep academic background allows him to bridge clinical research, informatics, and patient-centered interventions—a combination that has enabled his innovative work in cancer disparities and technology-enhanced health solutions.

Professional Experience

Dr. Tarver’s professional journey is defined by a blend of academic, clinical, and administrative roles that support his contributions to cancer prevention, health equity, and public health informatics. Currently serving as an Assistant Professor in the Division of Cancer Prevention and Control within the Department of Internal Medicine at The Ohio State University, he has held this role since 2019. Prior to this appointment, he was a postdoctoral and informatics fellow at the Roudebush VA Medical Center and Indiana University–Purdue University Indianapolis. During his time at the VA, Dr. Tarver contributed to the Center for Health Information and Communication, refining his expertise in applying informatics to support equitable healthcare delivery. His professional roles also extend into quality improvement, where he co-led the Health Equity Core at OSU’s Quality Improvement Hub from 2022 to 2024. Dr. Tarver is an active mentor in OSU’s Center for Cancer Health Equity Summer Research Program, guiding underrepresented students in impactful, community-focused projects. In addition, he participates in institutional governance as a member of OSU’s Innovation Council. Across his roles, he has demonstrated consistent leadership, interdisciplinary collaboration, and a deep commitment to improving health outcomes through equitable and data-driven approaches.

Research Interests

Dr. Tarver’s research is driven by a deep commitment to eliminating disparities in cancer prevention and control through the integration of technology, public health, and clinical practice. His primary interest lies in the development and evaluation of patient-centered technologies—particularly electronic patient-reported outcomes (ePRO) tools—to better engage underserved populations and inform health system decision-making. His projects explore how these tools can be tailored to the unique needs of minority communities, improve cancer survivorship planning, and enhance real-time communication between patients and providers. Another major area of interest is health equity, where Dr. Tarver investigates the impact of perceived discrimination, systemic biases, and cultural barriers on cancer care utilization and outcomes. Additionally, he is involved in research that evaluates educational interventions designed to reduce STEM-related biases in high school learning environments. Through his interdisciplinary work, Dr. Tarver aims to generate actionable insights that not only contribute to academic knowledge but also guide policy reforms and clinical practices. His interests span behavioral oncology, implementation science, and medical informatics, positioning him at the forefront of translational research that impacts patient lives while advancing health equity on a systemic scale.

Research Skills

Dr. Tarver possesses a robust skill set in both qualitative and quantitative research methodologies, which he applies to projects at the intersection of health equity, informatics, and cancer prevention. He is highly experienced in designing and analyzing patient-reported outcomes (PROs), particularly within underserved and minority populations. His expertise includes conducting structured interviews, participant observation, and systematic reviews—skills he actively shares as a guest lecturer in OSU’s Public Health Informatics course. Dr. Tarver is also proficient in research related to intervention development and evaluation, including randomized trials and implementation science frameworks. His grant-writing capabilities are demonstrated by his role as Principal Investigator (PI) and Co-Investigator (Co-I) on several federal and institutional research awards. He collaborates across disciplines, including clinical medicine, education, behavioral science, and information systems, to build comprehensive research designs. Additionally, he has applied informatics tools for data visualization, regulatory decision-making, and game-based learning assessments. These skills empower him to execute complex, multilevel projects with real-world applicability and high translational value. His research toolkit is complemented by strong mentorship abilities, fostering new talent and promoting equity-focused research within academic and clinical settings.

Awards and Honors

Dr. Tarver has received multiple prestigious honors that reflect his academic excellence, research promise, and commitment to advancing health equity. He was honored with the Young Investigator Award at the VA Medical Center in Indianapolis, recognizing his early-career contributions to cancer prevention research. His selection for the VA Advanced Fellowship in Medical Informatics further highlights his potential as a leader in data-driven health solutions. As a fellow in Behavioral Oncology at Indiana University, he gained national recognition for his work integrating psychological, behavioral, and technological approaches to patient-centered care. Notably, he was a recipient of the Diversity Supplement from the National Cancer Institute (NCI) through the University of Alabama at Birmingham, affirming his focus on minority health and health disparities. Earlier in his academic journey, he was awarded the ALSTARS Scholarship at the University of South Florida for academic merit and leadership. These accolades not only reflect his dedication to research excellence but also underscore the national recognition he has received for addressing some of the most pressing challenges in health equity, cancer care, and public health education.

Conclusion

In conclusion, Dr. Willi L. Tarver stands out as an exceptionally well-rounded and impactful academic professional whose contributions significantly advance the fields of cancer prevention, public health informatics, and health equity. His ability to bridge research, mentorship, education, and clinical innovation uniquely qualifies him for the Best Researcher Award. Through interdisciplinary training, funded research projects, and active mentorship, Dr. Tarver continues to address real-world health disparities and improve patient outcomes, particularly in underserved communities. His track record as a Principal Investigator and collaborator on diverse research grants highlights his leadership and collaborative capabilities. Moreover, his mentorship of minority students and involvement in institutional quality improvement initiatives reflect a long-term investment in both people and systems. With a growing portfolio of honors, active society memberships, and educational contributions, Dr. Tarver is positioned for continued excellence and recognition in the academic and public health communities. His work exemplifies the values of translational research, social impact, and scientific integrity, making him a deserving and distinguished candidate for the Best Researcher Award.

Publications Top Notes

1. Family structure and risk behaviors: the role of the family meal in assessing likelihood of adolescent risk behaviors
📅 Year: 2014
✍️ Authors: S. Goldfarb, W.L. Tarver, B. Sen
📰 Psychology Research and Behavior Management, pp. 53–66
📈 Citations: 83

2. The use of cancer-specific patient-centered technologies among underserved populations in the United States: systematic review
📅 Year: 2019
✍️ Authors: W.L. Tarver, D.A. Haggstrom
📰 Journal of Medical Internet Research, 21(4), e10256
📈 Citations: 68

3. Growth dynamics of patient-provider internet communication: trend analysis using the Health Information National Trends Survey (2003 to 2013)
📅 Year: 2018
✍️ Authors: W.L. Tarver, T. Menser, B.W. Hesse, T.J. Johnson, E. Beckjord, E.W. Ford, et al.
📰 Journal of Medical Internet Research, 20(3), e109
📈 Citations: 56

4. A systematic review of the association between family meals and adolescent risk outcomes
📅 Year: 2015
✍️ Authors: S.S. Goldfarb, W.L. Tarver, J.L. Locher, J. Preskitt, B. Sen
📰 Journal of Adolescence, 44, pp. 134–149
📈 Citations: 56

5. Exploring disparities and variability in perceptions and self-reported colorectal cancer screening among three ethnic subgroups of US Blacks
📅 Year: 2010
✍️ Authors: C.K. Gwede, C.M. William, K.B. Thomas, W.L. Tarver, G.P. Quinn, et al.
📰 Oncology Nursing Forum, 37(5), 581
📈 Citations: 51

6. A randomized trial to compare a tailored web-based intervention and tailored phone counseling to usual care for increasing colorectal cancer screening
📅 Year: 2018
✍️ Authors: V.L. Champion, S.M. Christy, W. Rakowski, W.G. Gathirua-Mwangi, W.L. Tarver, et al.
📰 Cancer Epidemiology, Biomarkers & Prevention, 27(12), 1433–1441
📈 Citations: 35

7. The impact of health information technology on cancer care across the continuum: a systematic review and meta-analysis
📅 Year: 2016
✍️ Authors: W.L. Tarver, N. Menachemi
📰 Journal of the American Medical Informatics Association, 23(2), 420–427
📈 Citations: 35

8. Perceptions of colorectal cancer among three ethnic subgroups of US blacks: a qualitative study
📅 Year: 2011
✍️ Authors: C.K. Gwede, E. Jean-Francois, G.P. Quinn, S. Wilson, W.L. Tarver, K.B. Thomas, et al.
📰 Journal of the National Medical Association, 103(8), 669–680
📈 Citations: 35

9. Allostatic load: a framework to understand breast cancer outcomes in Black women
📅 Year: 2021
✍️ Authors: S. Obeng-Gyasi, W. Tarver, R.C. Carlos, B.L. Andersen
📰 NPJ Breast Cancer, 7(1), 100
📈 Citations: 34

10. Factors associated with adherence to mammography screening among insured women differ by income levels
📅 Year: 2018
✍️ Authors: W. Gathirua-Mwangi, A. Cohee, W.L. Tarver, A. Marley, E. Biederman, et al.
📰 Women’s Health Issues, 28(5), 462–469
📈 Citations: 34